Back

Spotting the Silent Threat: Early Detection of Subclinical Tuberculosis in High-Risk Individuals

Daniel, E. A.; Nesakumar, M.; Haribabu, H.; Hilda, N.; Thiruvengadam, K.; Vetrivel, U.; Selvaraj, A.; Pattabiraman, S.; Bhanu, B.; Sivaprakasam, A.; Natarajan, S.; Kulkarni, V.; Karyakarte, R.; Paradkar, M.; Bala Yogendra Shivakumar, S. V.; Mave, V.; Chandrasekaran, P.; Gupta, A.; Hanna, L. E.

2025-02-24 infectious diseases Community evaluation
10.1101/2025.02.24.25322763 medRxiv
Show abstract

The dynamic spectrum of TB often results in underdiagnosis warranting the need for better diagnostics to accurately detect Mtb in diagnostically challenging cohorts. Household contacts of newly diagnosed TB patients who developed TB (Progressors) and those who remained healthy (Non-progressors) during a two-year follow-up cohort study were included. Mtb ccfDNA was detected in the plasma by targeting insertion sequences IS6110 and IS1081 using ddPCR. The assay yielded a sensitivity of 90{middle dot}9% in detecting subclinical TB cases and 81{middle dot}8% in possible TB cases. Further, the test detected Mtb ccfDNA in progressors even at six months prior to TB diagnosis at a sensitivity of 79{middle dot}0%. In about 55{middle dot}0% and 50{middle dot}0% of cases Mtb ccfDNA could be detected as early as 12 months and 18 months prior to development of active disease, respectively. The test demonstrated excellent sensitivity (100{middle dot}0%) in detecting extra-pulmonary TB cases up to six months prior to TB disease development.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.